alexa Epigenetic Approaches For The Treatment Of Alzheimer?s Disease | 21944
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

2nd International Conference on Alzheimers Disease and Dementia
September 23-25, 2014 Valencia Convention Centre, Spain

Mar Cuadrado-Tejedor, Carolina Garcia-Barroso, Julen Oyarzabal and Ana Garcia-Osta
ScientificTracks Abstracts: J Alzheimers Dis Parkinsonism
DOI: 10.4172/2161-0460.S1.006
Abstract
Alzheimer?s disesase (AD) drug development is mainly driven by the amyloid hypothesis. Unfortunately, the results of these drugs, that even may remove senile plaques, failed in reverting or stopping the dementia. Thus, it is emerging the idea that other pathways should be explored. Recent findings propose that epigenetic mechanisms, such as histone acetylation, are underlying memory deficits in AD. We become interested in Phenylbutyrate (PBA), as it is a drug that has potential properties that may be beneficial for AD. We demonstrated that PBA reverses memory deficits and the histopathological AD marks in the Tg2576 mouse model of the disease. HDAC inhibitors, like PBA, are being investigated for possible therapeutic effects in AD. It remains unclear which HDAC subtypes are involved in the pathophysiology of AD, and most of the HDACi tested are pan-HDACs. In terms of drug discovery, a greater selectivity may be required in terms of both specificity and safety. Specially, and since two isoforms, HDAC2 and HDAC6, seems to be the ones that may play a relevant role in the pathophysiology of AD, they should be the ones to be selectively inhibited. Based on this rational, in the last 2 years, we have been working in a novel strategy for the treatment of AD with a new generation of selective chemical compounds synthesized by the Small Molecule Drug Discovery platform at CIMA.
Biography
Mar Cuadrado-Tejedor got her PhD at University of Navarra, Spain in 2003. She is Associate Professor at the Department of Anatomy at School of Medicine at University of Navarra and forms part of Cellular and Molecular Neuropharmacology: Behaviour research team at the Center for Applied Medical Research (CIMA). Her research is mainly focused on finding new therapeutic targets for Alzheimer?s disease.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2018-19
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2018 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version